Innovita Biological Technology Co., Ltd., commonly known as INNOVITA, is a biotechnology company specializing in the research, development, production, and sales of in vitro diagnostic POCT products. With subsidiaries in Tangshan, Beijing, and Guangzhou, INNOVITA has established itself as a reputable brand in the industry. Since its establishment in 2006, INNOVITA has focused on various technical platforms, including antigen and antibody preparation, virus culture, colloidal gold, ELISA, fluorescence chromatography, and immunofluorescence.

The company actively engages in national major infectious diseases research and public health projects, holding over ten national invention patents. INNOVITA's product range encompasses respiratory diagnosis tests, fertility tests, hepatitis tests, TORCH tests, cardiovascular tests, renal function tests, and more. With CE and ISO13485 certification, their products adhere to high quality standards.

INNOVITA has a widespread sales network covering all provinces and regions in China, as well as reaching Southeast Asia, the Middle East, Africa, Latin America, and the European Union. Driven by a customer-centric approach, INNOVITA strives to provide accurate and convenient diagnostic solutions. Their dedication to innovation and excellence has earned them recognition and accolades, including being named an Advanced Collective in the National Commendation Congress for Combating COVID-19 Pandemic.

With continuous growth and expansion, INNOVITA is poised to make a significant impact in the biotechnology industry